Begin typing your search...

Pharma stocks, oil companies, PSU banks: Three top picks from ace investor Madhusudan Kela

Renowned investor Madhusudan Kela has shared insights into his top three investment picks. Kela highlights the potential for growth in the Public Sector Undertaking (PSU) banks, pharmaceuticals

image for illustrative purpose

Pharma stocks, oil companies, PSU banks: Three top picks from ace investor Madhusudan Kela
X

1 Feb 2024 9:37 PM IST

Renowned investor Madhusudan Kela has shared insights into his top three investment picks. Kela highlights the potential for growth in the Public Sector Undertaking (PSU) banks, pharmaceuticals, and the tourism sector, with a specific focus on religious tourism.

1. Public Sector Banks:

Kela notes that public sector banks are currently trading at lower Price-to-Earnings (P/E) ratios compared to other public sector companies, presenting an opportunity for further potential rallies. Despite concerns related to governance, technology, and credit costs in the past, Kela believes these issues have diminished, and public sector banks now rival private banks in terms of performance.

The recent surge in banking stocks, particularly in PSU banks like Bank of India, Punjab & Sind Bank, UCO Bank, and Canara Bank post-budget, further supports Kela's positive outlook on this sector. The Nifty PSU Bank index closed 3.11 percent higher, indicating renewed investor confidence.

2. Public-Sector Oil Companies:

Kela also expresses interest in public-sector oil companies that are currently attractively valued. However, he remains cautious about investing in railway stocks at the current levels.

3. Tourism Sector - Focus on Religious Tourism:

Madhusudan Kela identifies the tourism sector, particularly religious tourism to destinations like Ayodhya, Ujjain, or Vaishno Devi, as having tremendous potential. He suggests that there may be hidden opportunities within the tourism industry, presenting a compelling investment proposition.

4. Pharma Stocks:

Kela expresses bullish sentiments on pharma stocks over the medium-term, citing the industry's demonstrated capability during the COVID-19 pandemic. He highlights the swift development of vaccines within a 12-18 month period as evidence of the sector's potential. Kela emphasizes that within the pharma sector, individual companies may offer lucrative investment opportunities.

Disclaimer: While sharing these insights, Madhusudan Kela advises caution and recommends consulting certified experts before making any investment decisions. As the investment landscape evolves, Kela's analysis provides valuable guidance for investors considering these sectors for potential returns.

Stocks Market Shares 
Next Story
Share it